Determination of Escherichia coli and Citrobacter koseri Isolates with OXA-48 Carbapenemase in Istanbul

Nazik H., Bektore B., Ongen B., Ozyurt M., Yazici H., Baylan O., ...Daha Fazla

TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, cilt.31, sa.6, ss.1502-1506, 2011 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 31 Sayı: 6
  • Basım Tarihi: 2011
  • Doi Numarası: 10.5336/medsci.2010-22148
  • Dergi Adı: TURKIYE KLINIKLERI TIP BILIMLERI DERGISI
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1502-1506
  • İstanbul Üniversitesi Adresli: Evet

Özet

Objective: Today, carbapenems are used as almost last choice for the treatment of infections with extended spectrum beta-lactamase (ESBL) producing pathogens. However, the prevalence of carbapenamase-producing strains in Enterobacteriaceae has been increasing over the last decade. In this study, carbapenem-resistant Escherichia coli and Citrobacter koseri isolates with OXA-48 carbapenemase obtained from hospitalized patients in different regions of Istanbul were investigated. Material and Methods: The strains were identified by conventional methods and VITEK 2 system. Antibiotic susceptibility test was performed using disc diffusion method, and extended-spectrum beta-lactamase production was investigated using the double-disc synergy and cefotaxime/boronic acid- cefotaxime/boronic acid/clavulanic acid tests. VITEK 2 system was used for determination of minimum inhibitory concentration (MIC) of the antibiotics. The MICs of imipenem and meropenem for the clinical isolates were also determined by E-tests. The carbapenemase production was investigated with modified Hodge test. beta-lactamase genes and plasmid mediated quinolone resistance (PMQR) determinants were screened by polymerase chain reaction (PCR). The amplification products of bla(OXA-48) genes were sequenced. Conjugation experiment was used for transferring beta-lactamase gene. Results: The clinical isolates and their transconjugants were positive for bla(OXA-48), however, the isolates lacked PMQR and other beta-lactamase genes such as bla(TEM), bla(SHV), bla(CTX-M), bla(VIM), and bla(KPC). The bla(OXA-48) genes detected in both of the isolates were transferred to the recipient strain. The MICs were increased approximately two fold according to recipient strain in transconjugants for carbapenems. Additionally, the transconjugants conferred resistance to ampicillin, amoxicillin-clavulanic acid, piperacillin-tazobactam and cefazolin. Conclusions: The carbapenemase-producing isolates may restrict the use of these valuable antibiotics. In Turkey, the bla(OXA-48) gene not only persists especially in ICIebsiella pneumoniae but also it has spread among other species. The presence of OXA-48 carbapenemase in rarely encountered species should also be considered.

Determination of Escherichia coli and Citrobacter koseri Isolates with OXA-48 Carbapenemase in Istanbul

By:Nazik, H (Nazik, Hasan)[ 1 ] ; Bektore, B (Bektore, Bayhan)[ 2 ] ; Ongen, B (Ongen, Betigul)[ 1 ] ; Ozyurt, M (Ozyurt, Mustafa)[ 2 ] ; Yazici, H (Yazici, Halil)[ 3 ] ; Baylan, O (Baylan, Orhan)[ 2 ] ; Haznedaroglu, T (Haznedaroglu, Tuncer)[ 2 ]

 

TURKIYE KLINIKLERI TIP BILIMLERI DERGISI

 

Volume: 31

 

Issue: 6

 

Pages: 1502-1506

DOI: 10.5336/medsci.2010-22148

Published: DEC 2011

View Journal Information

Abstract

Objective: Today, carbapenems are used as almost last choice for the treatment of infections with extended spectrum beta-lactamase (ESBL) producing pathogens. However, the prevalence of carbapenamase-producing strains in Enterobacteriaceae has been increasing over the last decade. In this study, carbapenem-resistant Escherichia coli and Citrobacter koseri isolates with OXA-48 carbapenemase obtained from hospitalized patients in different regions of Istanbul were investigated. Material and Methods: The strains were identified by conventional methods and VITEK 2 system. Antibiotic susceptibility test was performed using disc diffusion method, and extended-spectrum beta-lactamase production was investigated using the double-disc synergy and cefotaxime/boronic acid- cefotaxime/boronic acid/clavulanic acid tests. VITEK 2 system was used for determination of minimum inhibitory concentration (MIC) of the antibiotics. The MICs of imipenem and meropenem for the clinical isolates were also determined by E-tests. The carbapenemase production was investigated with modified Hodge test. beta-lactamase genes and plasmid mediated quinolone resistance (PMQR) determinants were screened by polymerase chain reaction (PCR). The amplification products of bla(OXA-48) genes were sequenced. Conjugation experiment was used for transferring beta-lactamase gene. Results: The clinical isolates and their transconjugants were positive for bla(OXA-48), however, the isolates lacked PMQR and other beta-lactamase genes such as bla(TEM), bla(SHV), bla(CTX-M), bla(VIM), and bla(KPC). The bla(OXA-48) genes detected in both of the isolates were transferred to the recipient strain. The MICs were increased approximately two fold according to recipient strain in transconjugants for carbapenems. Additionally, the transconjugants conferred resistance to ampicillin, amoxicillin-clavulanic acid, piperacillin-tazobactam and cefazolin. Conclusions: The carbapenemase-producing isolates may restrict the use of these valuable antibiotics. In Turkey, the bla(OXA-48) gene not only persists especially in ICIebsiella pneumoniae but also it has spread among other species. The presence of OXA-48 carbapenemase in rarely encountered species should also be considered.